Published in J Immunol on June 15, 2001
The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity (2008) 10.55
Biology of interleukin-22. Semin Immunopathol (2010) 2.92
Interleukin-1beta selectively expands and sustains interleukin-22+ immature human natural killer cells in secondary lymphoid tissue. Immunity (2010) 2.67
IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. Nature (2012) 2.36
A role for T cell-derived interleukin 22 in psoriatic skin inflammation. Clin Exp Immunol (2007) 2.16
Interleukin-10 suppression of myeloid cell activation--a continuing puzzle. Immunology (2004) 1.95
Interleukin-22: immunobiology and pathology. Annu Rev Immunol (2015) 1.60
Structure of IL-22 bound to its high-affinity IL-22R1 chain. Structure (2008) 1.23
Cloning of a new type II cytokine receptor activating signal transducer and activator of transcription (STAT)1, STAT2 and STAT3. Biochem J (2003) 1.20
Aberrant expression of IL-22 receptor 1 and autocrine IL-22 stimulation contribute to tumorigenicity in ALK+ anaplastic large cell lymphoma. Leukemia (2008) 1.16
Membrane-bound IL-22 after de novo production in tuberculosis and anti-Mycobacterium tuberculosis effector function of IL-22+ CD4+ T cells. J Immunol (2011) 1.12
Inhibition of interleukin-22 attenuates bacterial load and organ failure during acute polymicrobial sepsis. Infect Immun (2007) 1.06
Structural analysis of cytokines comprising the IL-10 family. Cytokine Growth Factor Rev (2010) 0.99
Exonization of the LTR transposable elements in human genome. BMC Genomics (2007) 0.99
IL-22 in tissue-protective therapy. Br J Pharmacol (2013) 0.98
Healing of intestinal inflammation by IL-22. Inflamm Bowel Dis (2012) 0.97
Interleukin-22 binding protein (IL-22BP) is constitutively expressed by a subset of conventional dendritic cells and is strongly induced by retinoic acid. Mucosal Immunol (2013) 0.94
Roles of IL-22 in Allergic Airway Inflammation. J Allergy (Cairo) (2013) 0.88
Role of TH17 cytokines in the control of colorectal cancer. Oncoimmunology (2013) 0.87
Interleukin-22 forms dimers that are recognized by two interleukin-22R1 receptor chains. Biophys J (2007) 0.85
Donor interleukin-22 and host type I interferon signaling pathway participate in intestinal graft-versus-host disease via STAT1 activation and CXCL10. Mucosal Immunol (2015) 0.82
Interleukin-22 Signaling in the Regulation of Intestinal Health and Disease. Front Cell Dev Biol (2016) 0.80
STAT3-Activating Cytokines: A Therapeutic Opportunity for Inflammatory Bowel Disease? J Interferon Cytokine Res (2015) 0.80
Biological and pathological activities of interleukin-22. J Mol Med (Berl) (2016) 0.80
Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes. J Neuroinflammation (2015) 0.80
The multiple sclerosis risk gene IL22RA2 contributes to a more severe murine autoimmune neuroinflammation. Genes Immun (2014) 0.79
Differential Requirements for IL-17A and IL-22 in Cecal versus Colonic Inflammation Induced by Helicobacter hepaticus. Am J Pathol (2015) 0.78
Cytokine crowdsourcing: multicellular production of TH17-associated cytokines. J Leukoc Biol (2014) 0.78
Crystallization and preliminary X-ray diffraction analysis of human IL-22 bound to the extracellular IL-22R1 chain. Acta Crystallogr Sect F Struct Biol Cryst Commun (2008) 0.77
IL-22BP is produced by eosinophils in human gut and blocks IL-22 protective actions during colitis. Mucosal Immunol (2015) 0.77
Deletion of the entire interferon-γ receptor 1 gene causing complete deficiency in three related patients. J Clin Immunol (2016) 0.76
Mechanisms of immunomodulation by mammalian and viral decoy receptors: insights from structures. Nat Rev Immunol (2016) 0.76
The Role of IL-22 in Viral Infections: Paradigms and Paradoxes. Front Immunol (2016) 0.76
How Does Interleukin-22 Mediate Liver Regeneration and Prevent Injury and Fibrosis? J Immunol Res (2016) 0.75
A Functional IL22 Polymorphism (rs2227473) Is Associated with Predisposition to Childhood Cerebral Malaria. Sci Rep (2017) 0.75
Innate-like function of memory Th17 cells for enhancing endotoxin-induced acute lung inflammation through IL-22. Int Immunol (2015) 0.75
Association between CXCR2 and IL-22BP expression indicate a poor outcome for gastric adenocarcinoma progression. Oncol Lett (2016) 0.75
All of the twos, 22-bingo! J Am Soc Nephrol (2014) 0.75
Diagnostic value of interleukin 22 and carcinoembryonic antigen in tuberculous and malignant pleural effusions. Exp Ther Med (2011) 0.75
Crystallization and preliminary X-ray diffraction analysis of human IL-22 bound to its soluble decoy receptor IL-22BP. Acta Crystallogr Sect F Struct Biol Cryst Commun (2009) 0.75
Interleukin-22 in Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation. Front Immunol (2016) 0.75
Oral Administration of Lactobacillus rhamnosus GG Ameliorates Salmonella Infantis-Induced Inflammation in a Pig Model via Activation of the IL-22BP/IL-22/STAT3 Pathway. Front Cell Infect Microbiol (2017) 0.75
A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med (1994) 5.03
BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity (1995) 3.13
Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J Immunol (2000) 2.71
Interleukin-9 reduces lung fibrosis and type 2 immune polarization induced by silica particles in a murine model. Am J Respir Cell Mol Biol (2001) 2.37
cDNA cloning of murine interleukin-HP1: homology with human interleukin 6. Eur J Immunol (1988) 2.26
Interleukin-9 upregulates mucus expression in the airways. Am J Respir Cell Mol Biol (2000) 2.25
Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. J Immunol (2001) 2.07
Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor. Proc Natl Acad Sci U S A (2000) 2.01
Hepatic [14C]aminopyrine demethylation capacity after portocaval shunting. Comparative study in patients with and without arterialization of portal vein. Dig Dis Sci (1993) 1.94
Interleukin-9 is involved in host protective immunity to intestinal nematode infection. Eur J Immunol (1997) 1.87
Cloning and characterization of a cDNA for a new mouse T cell growth factor (P40). J Exp Med (1989) 1.73
Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity. Lupus (1995) 1.63
Interleukin-9 promotes allergen-induced eosinophilic inflammation and airway hyperresponsiveness in transgenic mice. Am J Respir Cell Mol Biol (1998) 1.60
A single tyrosine of the interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9. Mol Cell Biol (1996) 1.58
A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3. Proc Natl Acad Sci U S A (2001) 1.49
Anti-IL-9 vaccination prevents worm expulsion and blood eosinophilia in Trichuris muris-infected mice. Proc Natl Acad Sci U S A (2000) 1.46
IL-TIF/IL-22: genomic organization and mapping of the human and mouse genes. Genes Immun (2000) 1.45
Interleukin-9 enhances resistance to the intestinal nematode Trichuris muris. Infect Immun (1998) 1.42
Transcript synthesis and surface expression of the interleukin-2 receptor (alpha-, beta-, and gamma-chain) by normal and malignant myeloid cells. Blood (1996) 1.40
Genes coding for tumor antigens recognized by cytolytic T lymphocytes. Immunol Rev (1995) 1.38
Interleukin-9 potentiates the interleukin-4-induced immunoglobulin (IgG, IgM and IgE) production by normal human B lymphocytes. Eur J Immunol (1993) 1.35
Complementation of a threonine dehydratase-deficient Nicotiana plumbaginifolia mutant after Agrobacterium tumefaciens-mediated transfer of the Saccharomyces cerevisiae ILV1 gene. Mol Cell Biol (1987) 1.34
Intraepithelial infiltration by mast cells with both connective tissue-type and mucosal-type characteristics in gut, trachea, and kidneys of IL-9 transgenic mice. J Immunol (1998) 1.33
Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18. Cytokine (1999) 1.33
High frequency of cytolytic T lymphocytes directed against a tumor-specific mutated antigen detectable with HLA tetramers in the blood of a lung carcinoma patient with long survival. Cancer Res (2001) 1.26
Interleukin-9 expression in human malignant lymphomas: unique association with Hodgkin's disease and large cell anaplastic lymphoma. Blood (1991) 1.25
Mouse plasmacytoma growth in vivo: enhancement by interleukin 6 (IL-6) and inhibition by antibodies directed against IL-6 or its receptor. J Exp Med (1990) 1.24
Interleukin 9-induced in vivo expansion of the B-1 lymphocyte population. J Exp Med (1999) 1.23
Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18. J Immunol (2000) 1.22
IL-9 induces chemokine expression in lung epithelial cells and baseline airway eosinophilia in transgenic mice. Eur J Immunol (1999) 1.22
IL-9 induces expression of granzymes and high-affinity IgE receptor in murine T helper clones. J Immunol (1995) 1.17
A cascade of cytokines is responsible for IL-9 expression in human T cells. Involvement of IL-2, IL-4, and IL-10. J Immunol (1995) 1.17
Proinflammatory cytokines and interleukin-9 exacerbate excitotoxic lesions of the newborn murine neopallium. Ann Neurol (2000) 1.15
Bcl-3 expression promotes cell survival following interleukin-4 deprivation and is controlled by AP1 and AP1-like transcription factors. Mol Cell Biol (2000) 1.15
STAT5 activation is required for interleukin-9-dependent growth and transformation of lymphoid cells. Cancer Res (2000) 1.14
The IL-9 receptor gene, located in the Xq/Yq pseudoautosomal region, has an autosomal origin, escapes X inactivation and is expressed from the Y. Hum Mol Genet (1997) 1.08
IL9 maps to mouse chromosome 13 and human chromosome 5. Immunogenetics (1990) 1.07
Costimulation with B7-1, IL-6, and IL-12 is sufficient for primary generation of murine antitumor cytolytic T lymphocytes in vitro. J Immunol (1995) 1.06
Blockade of interleukin-12 function by protein vaccination attenuates atherosclerosis. Circulation (2005) 1.06
Distinct roles for STAT1, STAT3, and STAT5 in differentiation gene induction and apoptosis inhibition by interleukin-9. J Biol Chem (1999) 1.05
IL-9 protects mice from Gram-negative bacterial shock: suppression of TNF-alpha, IL-12, and IFN-gamma, and induction of IL-10. J Immunol (2000) 1.05
High frequency of autologous anti-melanoma CTL directed against an antigen generated by a point mutation in a new helicase gene. J Immunol (2000) 1.02
I-309/T cell activation gene-3 chemokine protects murine T cell lymphomas against dexamethasone-induced apoptosis. J Immunol (1996) 1.02
Expression of interleukin-9 leads to Th2 cytokine-dominated responses and fatal enteropathy in mice with chronic Schistosoma mansoni infections. Infect Immun (2000) 1.02
IL-2 dependence of IL-9 expression in human T lymphocytes. J Immunol (1992) 1.01
Interleukin 9 and its receptor: an overview of structure and function. Int Rev Immunol (1998) 1.01
Role of interleukin-10 in the lung response to silica in mice. Am J Respir Cell Mol Biol (1998) 1.00
IL-4-independent regulation of in vivo IL-9 expression. J Immunol (1997) 1.00
Interleukin-9 regulates NF-kappaB activity through BCL3 gene induction. Blood (1999) 1.00
The majority of autologous cytolytic T-lymphocyte clones derived from peripheral blood lymphocytes of a melanoma patient recognize an antigenic peptide derived from gene Pmel17/gp100. J Invest Dermatol (1996) 0.99
Autonomous growth and tumorigenicity induced by P40/interleukin 9 cDNA transfection of a mouse P40-dependent T cell line. J Exp Med (1991) 0.97
The expression of mouse gene P1A in testis does not prevent safe induction of cytolytic T cells against a P1A-encoded tumor antigen. Int J Cancer (1997) 0.96
Identification of genes coding for tumor antigens recognized by cytolytic T lymphocytes. Methods (1997) 0.95
Interleukin-10 blockade corrects impaired in vitro cellular immune responses of systemic lupus erythematosus patients. Arthritis Rheum (2000) 0.94
Effect of zolpidem on sleep and ventilatory patterns at simulated altitude of 4,000 meters. Am J Respir Crit Care Med (1996) 0.94
Lung fibrosis induced by silica particles in NMRI mice is associated with an upregulation of the p40 subunit of interleukin-12 and Th-2 manifestations. Am J Respir Cell Mol Biol (1999) 0.92
An antigen recognized by autologous CTLs on a human bladder carcinoma. J Immunol (1998) 0.91
Human T cell lines and clones respond to IL-9. J Immunol (1993) 0.90
Oxidative burst in lipopolysaccharide-activated human alveolar macrophages is inhibited by interleukin-9. Eur Respir J (2002) 0.88
Murine adseverin (D5), a novel member of the gelsolin family, and murine adseverin are induced by interleukin-9 in T-helper lymphocytes. Mol Cell Biol (1998) 0.86
Interleukin-9-induced expression of M-Ras/R-Ras3 oncogene in T-helper clones. Blood (1999) 0.86
Signalling by cytokines interacting with the interleukin-2 receptor gamma chain. Cytokines Cell Mol Ther (1998) 0.86
Deleterious effects of IL-9-activated mast cells and neuroprotection by antihistamine drugs in the developing mouse brain. Pediatr Res (2001) 0.84
Regional localization of the human glutaminase (GLS) and interleukin-9 (IL9) genes by in situ hybridization. Cytogenet Cell Genet (1991) 0.83
Mouse IL-6. A hybridoma growth factor with multiple effects on normal B and T cells. Ann N Y Acad Sci (1989) 0.83
IL-12 inhibits in vitro immunoglobulin production by human lupus peripheral blood mononuclear cells (PBMC). Clin Exp Immunol (1997) 0.83
Interleukin-9 stimulates in vitro growth of mouse thymic lymphomas. Eur J Immunol (1993) 0.83
Soluble tumor necrosis factor (TNF) receptors p55 and p75 and interleukin-10 downregulate TNF-alpha activity during the lung response to silica particles in NMRI mice. Am J Respir Cell Mol Biol (1999) 0.83
Clinical trials of antidepressants: the hidden face: where locus of control appears to play a key role in depression outcome. Psychopharmacology (Berl) (1995) 0.82
Usefulness of delayed postcontrast magnetic resonance imaging in the detection of residual cholesteatoma after canal wall-up tympanoplasty. Laryngoscope (2005) 0.82
Signals from the IL-9 receptor are critical for the early stages of human intrathymic T cell development. J Immunol (2000) 0.82
Differential activity of dexamethasone on IL-2-, IL-4-, or IL-9-induced proliferation of murine factor-dependent T cell lines. J Immunol (1996) 0.82
From health locus of control to immune control: internal locus of control has a buffering effect on natural killer cell activity decrease in major depression. Acta Psychiatr Scand (1995) 0.82
Ly-6A/E induction by interleukin-6 and interleukin-9 in T cells. Eur Cytokine Netw (1999) 0.82
Effects of normothermia versus hypothermia on extravascular lung water and serum cytokines during cardiopulmonary bypass: a randomized, controlled trial. Crit Care Med (2001) 0.81
Inhibition of in vitro immunoglobulin production by IL-12 in murine chronic graft-vs.-host disease: synergism with IL-18. Eur J Immunol (1998) 0.81
A deletion mutant of Pseudomonas exotoxin-A fused to recombinant human interleukin-9 (rhIL-9-ETA') shows specific cytotoxicity against IL-9-receptor-expressing cell lines. Cytokines Mol Ther (1996) 0.80
Interleukin-9 (IL-9) induces cell growth arrest associated with sustained signal transducer and activator of transcription activation in lymphoma cells overexpressing the IL-9 receptor. Cell Growth Differ (2001) 0.80
Interleukin-9 induces 24P3 lipocalin gene expression in murine T cell lymphomas. Eur Cytokine Netw (2001) 0.79
New MAGE-4 antigenic peptide recognized by cytolytic T lymphocytes on HLA-A1 tumor cells. Tissue Antigens (2003) 0.78
Plasmapheresis: an effective therapy for cholestatic episodes related to benign recurrent intrahepatic cholestasis? Ann Med Interne (Paris) (1988) 0.78
Nucleophosmin leukaemic mutants contain C-terminus peptides that bind HLA class I molecules. Leukemia (2007) 0.78
An animal model for anaplastic large cell lymphoma in the immunocompetent syngeneic C57Bl/6 mouse. Lab Invest (2000) 0.78
Role of insulin receptor substrate-2 in interleukin-9-dependent proliferation. FEBS Lett (2000) 0.78
Contribution of Kunitz protease inhibitor and transmembrane domains to amyloid precursor protein homodimerization. Neurodegener Dis (2012) 0.78
Hypokalemic rhabdomyolysis in anorexia nervosa. Acta Neurol Scand (1991) 0.77
Locus of control and metabolic control. Diabete Metab (1995) 0.77
Crystallization and synchrotron X-ray diffraction studies of human interleukin-22. Acta Crystallogr D Biol Crystallogr (2002) 0.76
Effects of chest wall counterpressures on lung mechanics under high levels of CPAP in humans. J Appl Physiol (1985) (1997) 0.75
Differential regulation by phorbol myristate acetate of IFN-gamma and IL-4 expression in anti-CD3 stimulated mouse spleen cells. Immunology (1992) 0.75
Diabetes mellitus and interferon therapy. Diabet Med (1997) 0.75
Molecular analysis of human interleukin-9 receptor transcripts in peripheral blood mononuclear cells. Identification of a splice variant encoding for a nonfunctional cell surface receptor. J Biol Chem (1998) 0.75
[Comparative value of anorectal manometry and electrocardiography in the diagnosis of diabetic autonomic neuropathy]. Gastroenterol Clin Biol (1987) 0.75
Caroli's disease -- diagnostic procedures and management 22 years after initial diagnosis. Acta Clin Belg (1983) 0.75
[Problems posed by use of alcohol by adolescents. Apropos of a survey in a school environment]. Ann Pediatr (Paris) (1986) 0.75
Increase of LBNP tolerance using elastic compression stockings. Aviat Space Environ Med (1996) 0.75